Snap-8 is described as a synthetic topical cosmetic peptide also known as Acetyl Octapeptide-3. The source frames it as a skincare ingredient researched for expression lines and wrinkle appearance, with limited human evidence and no drug-approval status.

How does Snap-8 work?

The proposed model is that Snap-8 resembles a portion of SNAP-25 and may interfere with SNARE-complex signaling involved in acetylcholine release. The source emphasizes that this remains a proposed topical cosmetic mechanism, with uncertainty about skin penetration and whether meaningful facial-muscle effects occur in vivo.

Is Snap-8 FDA approved?

No. The supplied source lists Snap-8 as not FDA approved and describes its status as cosmetic skincare use rather than an approved drug indication.

What are the side effects of Snap-8?

The source reports generally good tolerability, possible early tingling, possible mild irritation at higher concentrations, and no systemic toxicity. These are source-reported cosmetic-use observations and should not be treated as a complete safety profile.

What is the typical dose of Snap-8?

The source reports limited community dose information and points to research-use topical formulations of 3-10%. It does not establish an approved or clinically validated dosing schedule.

Skin & Hair Research - early research

Snap-8

Also known as: Acetyl Octapeptide-3, SNAP-8

At a glance

PeptiGuide dataset · reviewed Aug 2026

What it is

Topical cosmetic peptide researched for expression lines and wrinkle appearance.

Status

Research

Evidence level: early research

Typical dose

Limited community data available

Topical

Researched for

Wrinkle reduction, expression lines, anti-aging skincare

Trial progress

PrePreclinical
IPhase I
IIPhase II
IIIPhase III
IVPhase IV
FDAFDA approved

Preclinical - Limited evidence and no established human dosing

Use the tools

In plain language

Synthetic topical cosmetic also called Acetyl Octapeptide-3.
Researched for wrinkle appearance, expression lines, and anti-aging skincare.
Source classifies it as cosmetic use with limited research evidence, not an FDA-approved drug.
Reported topical research formulations use 3-10%, while community dose data are limited.

How it's thought to work

Snap-8 is proposed to act as a SNAP-25-mimicking cosmetic that may disrupt steps in SNARE-complex signaling linked to acetylcholine release. The source presents this as a plausible mechanism based on sequence-related rationale and nonclinical work, while noting that delivery through skin and confirmation of muscle-level effects after topical use remain uncertain.

What the research shows

Where the research stands

The source characterizes SNAP-8-specific human evidence as limited and heavily dependent on manufacturer-linked material. It compares the evidence landscape with Argireline, where reported wrinkle-depth improvements in one early study are contrasted with later split-face findings that did not show a statistically significant -placebo difference. The source also highlights unresolved questions about topical penetration and whether the proposed muscle-inhibition mechanism has been demonstrated in living tissue.

What it shows

✓ Early research

Limited evidence and no established human dosing

△ Limitations

Early research findings may not translate directly to human outcomes.

Bottom line: Cosmetic skincare ingredient; widely available in skincare products Not FDA approved

Typical dosing

CommunityCommunity dataset

Limited community data available

See research protocols

Range: See research dosing

Community data in the source are sparse and do not establish a validated dosing regimen.

Research dosing

Early researchEarly research - limited data

Doses observed in studies

3-10% in topical formulations

Research Literature - Observed in studies

Early research findings may not translate directly to human outcomes.

Duration: Ongoing use for maintained effects
Administration: Topical (serums, creams)

Timing & administration

Best time to take

Evening (topical)

Once or twice daily topically

Food recommendation

No food-related timing issue is identified for topical use; source lists with or without food.

Why this timing?

Evening use is reported for topical application because the source associates it with overnight absorption during skincare routines.

Possible side effects

Not everyone experiences these. Individual responses vary with dose, duration, and personal factors.

Generally well tolerated
Mild tingling
Mild skin irritation
No systemic toxicity reported

Not everyone experiences side effects, and severity can vary by context, purity, route, and individual health factors.

Sources

PubMed ClinicalTrials.gov FDA.gov

Frequently asked questions

Sequence

Ac-EEMQRRAD-NH2

One open dataset

Every fact on this page - doses, side effects, references - comes from the same PeptiGuide dataset that powers the Tracker, Compare, and the Lab.

Browse the dataset

Save to my research list Get updates on Snap‑8

Educational resource, not medical advice. Talk to your clinician before acting on anything here.

Community discussion

Comments are moderated before they appear. Keep it evidence-focused.

Snap-8

In plain languageIn plain language

How it's thought to workHow it's thought to work

What the research showsWhat the research shows

Typical dosing

Research dosing

Timing & administrationTiming & administration

Possible side effectsPossible side effects

SourcesSources

Frequently asked questionsFrequently asked questions

What does Snap-8 do?